8-6
FDA clears Moderna’s mRNA flu vaccine mFLUSIVA for adults 50 and older
The U.S. Food and Drug Administration has approved Moderna’s mRNA-based seasonal flu vaccine, mFLUSIVA, for adults ages 50 and older, making it the first mRNA influenza shot cleared by the agency. The decision follows earlier pushback over the company’s application and broader criticism of mRNA technology, after Moderna revised its filing. Moderna said it expects mFLUSIVA to be available for the 2026-27 flu season.
8-6
8-5
Dow jumps 1,007 points as Caterpillar and Palantir earnings beat lift risk appetite
The Dow Jones Industrial Average surged 1,007 points, while the S&P 500 rose 142 points to 7,731 and the Nasdaq Composite gained 2.6%. Stocks advanced after Caterpillar (CAT) and Palantir (PLTR) posted results that topped expectations. Sentiment also improved after CNBC reported Treasury Secretary Scott Bessent saying progress tied to an Iran nuclear deal could reopen the Strait of Hormuz within 24–48 hours. All three major indexes are up 13%–14% so far this year.
8-5
7-17
FDA probes Taylor Farms iceberg lettuce from Mexico as possible source of cyclosporiasis outbreak spanning 34 states
U.S. health officials are investigating whether iceberg lettuce imported from Mexico and supplied by Taylor Farms may be tied to a cyclosporiasis outbreak that has spread to 34 states. Michigan alone has reported at least 4,312 confirmed cases. The lettuce was used by Taco Bell locations in five states where infected people ate, and the chain has moved to remove the ingredient from its supply chain nationwide and replace it within 24 hours in select states, according to a person familiar with the investigation who spoke to CBS News.
7-17
6-30
Medicare to launch GLP-1 weight-loss drug coverage pilot on July 1, 2026 with $50 monthly copay
The Centers for Medicare & Medicaid Services will begin an 18-month pilot program on July 1, 2026 to cover GLP-1 drugs prescribed for weight loss, including Eli Lilly’s (LLY) Zepbound and Foundayo and Novo Nordisk’s (NVO) Wegovy. Eligible Medicare beneficiaries will pay a $50 monthly copay and will not need to meet the Part D deductible. The program is expected to cover about 3.8 million patients and is scheduled to expire at the end of 2027, leaving future coverage uncertain.
6-30
6-25
U.S. Supreme Court rules 7-2 that federal pesticide law blocks Roundup cancer-warning lawsuits against Monsanto
The U.S. Supreme Court ruled 7-2 that federal pesticide law preempts state-law claims accusing Monsanto of failing to warn on Roundup labels about alleged cancer risks. The decision is expected to shut down thousands of similar suits and reduce Bayer’s Roundup-related legal exposure stemming from its 2018 acquisition of Monsanto. Bayer said it will keep pursuing final approval of a $7.25 billion proposed class settlement intended to resolve current and future Roundup claims, according to a statement shared with CBS News.
6-25
6-23
Five Eyes warn frontier AI could outpace cybersecurity defenses within months
The Five Eyes intelligence alliance said frontier AI models could outstrip current cybersecurity defenses within months, urging governments and businesses to accelerate preparations. After highlighting the risks of AI-enhanced hacking, the agencies said organizations should modernize systems, limit access to critical infrastructure and incorporate AI tools into security operations. Anthropic then suspended external access to Mythos 5 and a restricted version, Fable 5, to comply with a U.S. national security order that bars foreign nationals from using the models. The move underscores a shift from broad AI governance principles to direct, operational intervention in a rare instance of urgent enforcement in the sector.
6-23
6-19
Cuba passes nearly 200 free-market reforms as U.S. oil blockade deepens economic crisis
Cuba has approved its largest-ever set of free-market reforms as it seeks to avert an economic collapse, driven by a U.S. oil blockade imposed in January. The blockade has left the island with only one Russian oil tanker docking all year, worsening long blackouts and severe shortages of fuel and medicine. The United Nations has warned that children are dying due to a lack of medical supplies. The reforms open the door to foreign stakes in state firms and remove the joint-venture requirement, but they have not resolved the immediate energy supply disruption.
6-19